Fakeeh Care Group and Fosun Pharma forge strategic partnership
Dr. Mazen Soliman Fakeeh, President of Fakeeh Care Group, emphasized that this collaboration marks a significant step toward enhancing the Kingdom's healthcare system by introducing cutting-edge therapeutic and diagnostic technologies. 'Our goal is to build a sustainable healthcare ecosystem founded on research and innovation, and to ensure access to the world's most advanced medical solutions,' he stated.
The partnership reflects Fakeeh Care Group's commitment to working with trusted global players with a proven track record in pioneering and localizing advanced treatments. Fosun Pharma is an international frontrunner in biopharmaceuticals, CAR-T therapies and gene therapy. Its self-developed and approved biologics have benefited more than 750,000 patients worldwide.
In addition, Fosun Pharma has developed advanced platforms in diagnostics, medical devices, and AI-powered digital pathology, accelerating diagnostic processes and enabling effective tele-diagnostic solutions.
Commenting on the strategic alliance, Dr. Sohail Bajammal, CEO of Dr. Soliman Fakeeh Hospital in Jeddah, said: 'At Fakeeh Care, we are committed to transferring and localizing advanced medical technologies in Saudi Arabia—including CAR-T treatments for hematological cancers and autoimmune disorders, gene therapies for chronic diseases, and smart tele-diagnostic and monitoring systems.'
Mr. Guo Guangchang, Chairman of Fosun International, expressed his enthusiasm for the partnership: 'We look forward to establishing long-term and stable strategic cooperation with Fakeeh Care Group to realize our shared vision of delivering integrated healthcare globally. With Fosun's global operational capabilities, we intend to achieve sustainable value growth with our Middle Eastern partners and create a new win-win ecosystem."
The memorandum of understanding outlines that 'this future collaboration is more than a technological alliance; it is a shared commitment to reshaping the healthcare landscape in the Kingdom and the region.'
This partnership aspires to become a model of excellence in the GCC region for integrating advanced therapeutics and tele-diagnostics, positioning Saudi Arabia as a regional hub for healthcare innovation. Through this alliance, Fakeeh Care Group and Fosun Pharma reaffirm their joint commitment to transforming patient lives through innovation, building long-term strategic partnerships, and supporting the Kingdom's ambition to become a global center for advanced healthcare aligned with Vision 2030.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
4 days ago
- Zawya
Global Health Exhibition 2025: Turning healthcare tech startups into global industry leaders
Saudi Arabia's $1.5B digital health investment powers global startup momentum at Global Health Exhibition 20 finalists from across the world to pitch live in Riyadh—accelerating KSA's regional growth and global reach Riyadh, Saudi Arabia: Held under the patronage of the Ministry of Health and supported by Vision 2030 and the Health Sector Transformation Program, the Global Health Exhibition (GHE), organised by Tahaluf, has announced the return of the NextGen Pitch Competition. Taking place from 27 to 30 October on the Venture Forum stage, this flagship initiative serves as a launchpad for the world's most promising health technology startups and scaleups. By connecting innovators with capital, mentorship, and market access, the competition empowers emerging ventures to evolve into globally recognised industry leaders. Saudi Arabia is rapidly emerging as a powerhouse for startup investment in the region. In the first half of 2025 alone, the Kingdom deployed $860 million in venture capital, marking a 116% increase compared to the same period in 2024 and surpassing the total VC funding for all of last year[1]. This surge has solidified Saudi Arabia's position as the top VC destination in the MENA region, accounting for 56% of all capital deployed and 37% of total deals across the region[2]. These figures underscore the Kingdom's growing influence in shaping the future of health innovation and entrepreneurship. Transforming healthcare access across the Kingdom and beyond Now in its second edition, NextGen plays a pivotal role in advancing GHE's mission to establish Saudi Arabia as a global leader in healthcare innovation and investment. Aligned with Vision 2030 and the Health Sector Transformation Program, NextGen accelerates the adoption of digital health solutions that enhance access, equity, and health outcomes across the Kingdom and beyond. Open to digital health, MedTech, biotech, life sciences, public health, and clinical innovation ventures, the competition particularly welcomes companies advancing health access, equity, and preventative care. Startups from Saudi Arabia and around the world are encouraged to apply, with last year's cohort representing countries from across MENA, Asia, Europe, and North America. The competition will be evaluated by an esteemed panel of industry experts including, but not limited to, Dr. Jochen Hurlebaus, President & Owner of Aluna Healthcare Consulting (Switzerland); Jennifer Lum, Co-Founder & Managing Partner of Biospring Partners (USA); Rana Lonnen, Managing Director at Science Capital (Switzerland); Ibrahim Seksek, CEO of Startupbootcamp (UAE); Varun Turlapati, Managing Director of Chaanakya Capital (USA); and Pilar Fernandez Hermida, Managing Director of i-Expand (UAE), among others, who collectively bring decades of investment and healthcare innovation experience to identify the most promising ventures. A launchpad for growth, investment, and regional scale Participants in the competition will gain exclusive access to one-to-one investor matchmaking, expert mentorship from global industry leaders, and the opportunity to pitch live in front of over 300 investors, including venture capital firms, sovereign wealth funds and family offices. Early confirmed investment organisations include Deerfield, World Bank Group, PIF and ATEM Capital. The winning startup will receive a 100,000 SAR grand prize and a strategic platform to scale their solution across the region. Twenty companies will be shortlisted across two tracks: startups (bootstrapped to seed, under 2 million US dollars raised) and scaleups (Series A and beyond). Each team will deliver a three-minute pitch followed by a five-minute Q&A with the judging panel. Semi-finals will take place on 28 and 29 October, with the final and winner announcement on 30 October. In addition, the Global Health Exhibition is set to feature an Investment Forum (Days 2-4), offering startups and scaleups direct access to Saudi Arabia's dynamic healthcare investment landscape. The forum will provide clarity on regulatory frameworks, facilitate high-impact local partnerships, and connect investors with emerging opportunities. Day 4 will spotlight Procurement, featuring innovative purchasing models, supply chain solutions, and sustainable strategies aligned with Saudi Arabia's green initiatives. Building a track record of success The impact of the NextGen Pitch Competition is already becoming clear. Initially launched to spotlight emerging healthtech ventures, it has grown into a credible platform for early-stage companies to gain visibility, build networks, and accelerate their development. This year, the competition seeks to attract high-potential startups looking to engage with investors, partners, and the wider healthcare innovation ecosystem. Among last year's winners was Xgenome Biotech, a Saudi-founded startup developing next-generation diagnostic kits. Reflecting on the programme's influence, CEO Burhan Fakhurji said: 'Last October we had the honour of taking home first place in GHE's NextGen Pitch Competition. Since then, we have managed to progress that project from prototype stage. We are now in a position where we believe in 3-4 months - by the time of GHE 2025 - we will have our first kit ready. Without the advantage of winning the NextGen Pitch Competition and the trust we got from the onsite investors, we might not be in this exciting position.' Commenting on the competition's return, Rachel Sturgess, Senior Vice President at Tahaluf, said: "Saudi Arabia is rapidly becoming the launchpad for the next generation of healthcare innovation. Through the NextGen Pitch Competition, we are not only showcasing bold ideas but actively enabling their growth. By connecting startups with capital, expertise and access to one of the world's most ambitious healthcare markets, we are helping shape a future where innovation knows no borders." Applications are now open and close on 15 September 2025. Startups and scaleups interested in applying can visit: For more information on this year's programme, visit: About Global Health Exhibition Established in 2018, Global Health Exhibition (GHE) is Saudi Arabia's premier platform for showcasing next-generation healthcare innovation. GHE is organised by Tahaluf, a strategic alliance between Informa PLC, the Saudi Arabian Federation for Cyber Security and Programming (SAFCSP), and the Events Investment Fund (EIF). The event brings together global leaders, investors, and innovators to shape the future of healthcare. Set against the backdrop of Vision 2030, it positions Riyadh as a driving force in global health transformation. GHE spans the entire health ecosystem and welcomed over 105,000 attendees during its 2024 edition. Press & Media Inquiries:Jessica Homan, Tahaluf [1] Saudi Arabia Aggregates $860M of Venture Capital Deployment in H1 2025, Surpassing All of 2024 Funding, and Maintains Its Leading Position in MENA [2] Saudi Arabia Aggregates $860M of Venture Capital Deployment in H1 2025, Surpassing All of 2024 Funding, and Maintains Its Leading Position in MENA
Zawya
5 days ago
- Zawya
Saudi: Fakeeh group delivers H1 2025 revenue of $402.4mln, up 13% year-on-year
Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: 'In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities —investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah—developed in partnership with Yasser Yousef Naghi Investment Company—a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem—with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum—continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
5 days ago
- Zawya
Fakeeh Group delivers 1H 2025 revenue of SAR 1.51 bln, up 13% year-on-year
The Group advances hub‑and‑spoke expansion with DSFMC Al Zahraa groundbreaking; disciplined ramp up in Riyadh and Madinah underpin medium‑term growth trajectory Jeddah, KSA: Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announces today its financial result for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SAR 812 million (+24% YoY) and Net Profit after Zakat of SAR 68 million (+59% YoY); 1H‑2025 revenue was SAR 1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: ' In the second quarter of the year, Fakeeh Care Group revenues reached to SAR 812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SAR 154 million in the first half (SAR 82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah developed in partnership with Yasser Yousef Naghi Investment Company a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on About Fakeeh Care Group Established in 1978 by the late Dr. Soliman Fakeeh, the Fakeeh Care Group stands as a pioneer in integrated healthcare services in Saudi Arabia. Our comprehensive healthcare offering includes our core healthcare services ranging from ambulatory care to secondary and tertiary care, supported by Emergency Medical Services and Fakeeh Home Healthcare. Additionally, our offerings are enhanced by our industry-leading academic healthcare programs. Building on a strong track record of growth in our home city of Jeddah, the Group embarked on a Kingdom-wide expansion strategy to bring our well proven hub-and-spoke model and medical support services to major cities across Saudi Arabia. In June 2024, Fakeeh Care Group successfully concluded its initial public offering (IPO) on the Tadawul. The IPO raised gross proceeds of SAR 2.9 billion (US$ 764 million) for the Company and the Selling Shareholders of which SAR 1.7 billion will be used to support and accelerate the Group's growth strategy. For further information, please contact: Fakeeh Care Group e-mail: investors@
